Advertisement

Ads Placeholder
Loading...

Oaktree Acquisition Corp. III Life Sciences

OACCW•NASDAQ
Financial Services
Shell Companies
$0.75
$0.00(0.00%)
U.S. Market opens in 34h 43m

Oaktree Acquisition Corp. III Life Sciences (OACCW) Stock Overview

Explore Oaktree Acquisition Corp. III Life Sciences’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap18.5M
P/E Ratio1.98
EPS (TTM)N/A
ROE0.05%
Fundamental Analysis

AI Price Forecasts

1 Month$0.71
3 Months$0.78
1 Year Target$0.16

OACCW Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Oaktree Acquisition Corp. III Life Sciences (OACCW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 51.42, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.16.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 1.98 and a market capitalization of 18.5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
-3.85%
1-Month Change
N/A
3-Month Change
-21.05%
6-Month Change
-6.25%
Year-to-Date (YTD) Change
-21.05%
1-Year Change
-2.60%
3-Year Change
-2.60%
5-Year Change
-2.60%
All-Time (Max) Change
-2.60%

Contact Information

https://www.oaktreeacquisitioncorp.com/oac-iii
213 830 6300
333 South Grand Avenue, Los Angeles, CA, 90071

Company Facts

IPO DateOct 6, 2025
CountryUS
Actively Trading

Frequently Asked Questions